Subscribe

TherapeuticsMD, Inc. (TXMD)

USD1.97 -0.01 (-0.25%)
US NASDAQ Healthcare Drug Manufacturers - Specialty & Generic
Address 951 Yamato Road 33431
Boca Raton, FL, US
CEO Marlan D. Walker
IPO 2007-05-09
CIK 25743 ISIN US88338N2062

Explore sections of this company profile

Description

TherapeuticsMD, Inc. is a U.S.-based pharmaceutical company dedicated to women's health. Its marketed portfolio includes IMVEXXY, prescribed for moderate to severe dyspareunia; BIJUVA, a bio-identical hormone replacement therapy combining 17ß-estradiol and progesterone, used to alleviate moderate to severe vasomotor symptoms; and ANNOVERA, an innovative vaginal ring designed for contraception. In its developmental pipeline, TherapeuticsMD is advancing several preclinical candidates: TX-005HR, a transdermal cream containing only progesterone; TX-006HR, another transdermal cream formulated with both estradiol and progesterone; TX-007HR and TX-008HR, both experimental transdermal patches; and TX-009HR, an oral formulation of progesterone and estradiol. Beyond its core pharmaceutical offerings, the company produces and distributes both branded and generic prescription prenatal vitamins, notably under the vitaTrue, vitaPearl, vitaMedMD, and BocaGreenMD Prena1 labels. Its prescription medications and prenatal vitamin lines reach consumers through established channels, including wholesale and retail pharmacy distributors. Established in 2008, TherapeuticsMD, Inc. maintains its corporate headquarters in Boca Raton, Florida.

Market Cap & Enterprise Value
Merger & Acquisition History

No mergers or acquisitions recorded for this company.

Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary Loading…
Indicator 1D1W2W3W1M
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
Averages
Trend
Price
Levels
Draw
USD1.97 -0.01 (-0.25%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
38.0K
Beta
0.59
Float Shares
10.78M
Free Float %
93.1%
Price Performance
1D5D1M3M6M YTD1Y3Y5Y10YMax
+3.59% +2.54% -1.46% -14.41% +24.69% +23.93% +32.89% -53.99% -96.19% -99.48% -99.95%
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
vs.
Loading histogram data…

Revenue flow

Revenue by geography

Revenue by segment

From To

Revenue composition

From To

By product

By geography

Financial Statements

Income Statement

Balance Sheet

Cash Flow Statement

Key Metrics

Financial Ratios

Employees

Financial Growth (CAGR)

Market Data

Analyst Consensus (8 ratings, all time) Buy
Price Targets & DCF
Current price
1.97
Ratings Trend (MoM) 89% Bullish
Rating 2024-11 Change
Strong Buy 3 0
Buy 5 0
Hold 1 0
Sell 0 0
Strong Sell 0 0
Quality scores
Altman Z-Score
-34.09
Distress
Piotroski F-Score
6 / 9
Average
MOAT Score
2 / 10
No MOAT
Composite Rating
B
Overall Score
3 / 5
Medium
DCF Score
3 / 5
Medium
ROE Score
3 / 5
Medium
ROA Score
3 / 5
Medium
D/E Score
2 / 5
Medium
P/E Score
1 / 5
Low
P/Book Score
4 / 5
High
Operational MOAT
✗ Below peers
  • Revenue growth Drug Manufacturers - Specialty & Generic: +6.8%
    +71.6% Q1'26: -100.0% (vs Q1'25)
  • EPS growth Drug Manufacturers - Specialty & Generic: +16.5%
    +74.1% Q1'26: +117.7% (vs Q1'25)
  • FCF margin FCF growth · Drug Manufacturers - Specialty & Generic: +32.3%
    -44.9%
  • EBIT margin Drug Manufacturers - Specialty & Generic: +13.0%
    -139.4%
  • ROIC Drug Manufacturers - Specialty & Generic: +6.5%
    -17.2% Q1'26: +0.0% (vs Q1'25)
  • Share dilution Drug Manufacturers - Specialty & Generic: +0.0%
    +0.3% Q1'26: +0.8% (vs Q1'25)
  • Debt / EBITDA Net debt/EBITDA · Drug Manufacturers - Specialty & Generic: -0.10×
    -1.70× Q1'26: 6.12× (vs Q1'25)
Valuation Multiples From To
Price Forecast (3Y) From To
Model
Adjust
P/E
Theoretical Return — If Invested Today

* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.

DCF Interactive Model (UFCF)
Projection years:
Market assumptions
WACC components (optional)
Ke (Cost of Equity) = Rf + β (0.58) × ERP
WACC = 82% × Ke + 18% × Kd (4.1%) × (1−t)

Modifying these values recalculates WACC automatically.

Business assumptions
Current price: 1.97
Enterprise Value: Equity Value: Terminal Value: TV as % of EV:

Base values reflect the latest available data for this company and market conditions.

Consensus Estimates
Metric Dec 2015
actual
Dec 2016
actual
Dec 2017
actual
Dec 2018
actual
Dec 2019
actual
Dec 2020
actual
Dec 2021
actual
Dec 2022
actual
Dec 2023
actual
Dec 2024
actual
Dec 2025
actual
Dec 2026
1 Rev. Ana.
1 EPS Ana.
Dec 2027
1 Rev. Ana.
1 EPS Ana.
Revenue
20.14M
est: 19.80M (+1.7%)
19.36M
est: 20.78M (-6.8%)
16.78M
est: 17.58M (-4.6%)
16.10M
est: 15.61M (+3.1%)
49.65M
est: 46.97M (+5.7%)
64.87M
est: 63.06M (+2.9%)
2.57M
est: 97.28M (-97.4%)
69.96M
est: 70.00M (-0.1%)
1.30M
est: 2.00M (-34.9%)
1.76M
est: 9.00M (-80.4%)
3.02M
est: 9.20M (-67.2%)
9.30M
9.30M – 9.30M
+1.1% YoY
9.50M
9.50M – 9.50M
+2.2% YoY
EBITDA
-85.13M
est: -69.49M (-22.5%)
-89.74M
est: -78.45M (-14.4%)
-76.71M
est: -78.47M (+2.2%)
-127.65M
est: -125.03M (-2.1%)
-158.23M
est: -149.81M (-5.6%)
-153.41M
est: -48.31M (-217.5%)
-70.84M
est: -154.90M (+54.3%)
11.86M
est: -170.39M (+107.0%)
-8.08M
est: -187.43M (+95.7%)
-2.98M
est: -6.89M (+56.7%)
-3.02M
est: -7.05M (+57.1%)
-7.12M
-7.12M – -7.12M
-1.1% YoY
-7.28M
-7.28M – -7.28M
-2.2% YoY
EBIT
-85.19M
est: -69.64M (-22.3%)
-89.88M
est: -78.90M (-13.9%)
-76.93M
est: -79.40M (+3.1%)
-127.94M
est: -127.67M (-0.2%)
-159.62M
est: -147.30M (-8.4%)
-157.48M
est: -48.53M (-224.5%)
-71.58M
est: -158.98M (+55.0%)
10.66M
est: -174.88M (+106.1%)
-8.52M
est: -192.37M (+95.6%)
-3.49M
est: -6.93M (+49.6%)
-4.21M
est: -7.08M (+40.5%)
-7.16M
-7.16M – -7.16M
-1.1% YoY
-7.31M
-7.31M – -7.31M
-2.2% YoY
Net Income
-85.08M
est: -69.54M (-22.3%)
-89.88M
est: -78.57M (-14.4%)
-76.93M
est: -78.69M (+2.2%)
-132.62M
est: -130.35M (-1.7%)
-176.15M
est: -169.07M (-4.2%)
-183.52M
est: -355.19M (+48.3%)
-172.42M
est: -190.53M (+9.5%)
112.00M
est: 29.10M (+284.9%)
-10.28M
est: -8.90M (-15.5%)
-2.18M
est: 1.74M (-225.7%)
-569.0K
est: 1.85M (-130.7%)
1.97M
1.97M – 1.97M
+6.3% YoY
2.20M
2.20M – 2.20M
+11.8% YoY
SGA
28.72M
est: 127.04M (-77.4%)
51.35M
est: 133.29M (-61.5%)
57.70M
est: 112.80M (-48.8%)
115.99M
est: 100.15M (+15.8%)
174.73M
est: 301.28M (-42.0%)
194.01M
est: 404.55M (-52.0%)
72.75M
est: 624.05M (-88.3%)
56.71M
est: 449.05M (-87.4%)
est: 12.83M (-100.0%)
est: 56.43M (-100.0%)
6.85M
est: 57.69M (-88.1%)
58.31M
58.31M – 58.31M
+1.1% YoY
59.57M
59.57M – 59.57M
+2.2% YoY
EPS
-24.56
est: -24.63 (+0.3%)
-22.92
est: -23.21 (+1.3%)
-18.71
est: -17.99 (-4.0%)
-29.47
est: -29.43 (-0.1%)
-39.79
est: -34.86 (-14.1%)
-38.58
est: -30.80 (-25.3%)
-25.83
est: -20.17 (-28.1%)
-10.35
est: 11.96 (-186.5%)
-0.55
est: -0.75 (+26.7%)
-0.19
est: 0.15 (-226.7%)
-0.05
est: 0.16 (-130.8%)
0.17
0.17 – 0.17
+6.3% YoY
0.19
0.19 – 0.19
+11.8% YoY
Historical Ratings (3M)
Date Rating Overall DCF ROE ROA D/E P/E P/B
2026-05-13 B 3/5 3/5 3/5 3/5 2/5 1/5 4/5
2026-05-12 B 3/5 3/5 3/5 3/5 2/5 1/5 4/5
2026-05-11 C+ 2/5 3/5 1/5 1/5 2/5 1/5 5/5
2026-05-08 C+ 2/5 3/5 1/5 1/5 2/5 1/5 5/5
2026-05-07 C+ 2/5 3/5 1/5 1/5 2/5 1/5 5/5
2026-05-06 C+ 2/5 3/5 1/5 1/5 2/5 1/5 5/5
2026-05-05 C+ 2/5 2/5 1/5 1/5 2/5 1/5 5/5
2026-05-04 C+ 2/5 2/5 1/5 1/5 2/5 1/5 5/5
2026-05-01 C+ 2/5 3/5 1/5 1/5 2/5 1/5 5/5
2026-04-30 C+ 2/5 3/5 1/5 1/5 2/5 1/5 5/5
2026-04-29 C+ 2/5 3/5 1/5 1/5 2/5 1/5 5/5
2026-04-28 C+ 2/5 3/5 1/5 1/5 2/5 1/5 5/5
2026-04-27 C+ 2/5 3/5 1/5 1/5 2/5 1/5 5/5
2026-04-24 C+ 2/5 3/5 1/5 1/5 2/5 1/5 4/5
2026-04-23 C+ 2/5 3/5 1/5 1/5 2/5 1/5 4/5
2026-04-22 C+ 2/5 3/5 1/5 1/5 2/5 1/5 4/5
2026-04-21 C 2/5 3/5 1/5 1/5 1/5 1/5 4/5
2026-04-20 C 2/5 3/5 1/5 1/5 1/5 1/5 4/5
2026-04-17 C 2/5 3/5 1/5 1/5 1/5 1/5 4/5
2026-04-16 C 2/5 3/5 1/5 1/5 1/5 1/5 4/5

Owner Earnings

Owner's Earnings (history) From To
Owner alignment
Owner's Earnings TTM
3.93M
OE per share TTM
0.34
Owner's Yield
16.81%
Maintenance CapEx ratio
126.60%
Maint CapEx / Avg PPE
30.6%

Ownership Overview

Ownership breakdown
At a glance
Institutional holders
19
Total invested
1.58M
Insider transactions (90d)
0
Beneficial owners (>5%)
24
Beneficial owners (>5%)
# Reporting person Amount owned % of class Sole voting Shared voting Sole dispositive Shared dispositive Type Citizenship Filing date SEC filing
1 Deerfield Management Company, L.P. 20.66M 4.90% 20.66M PN Delaware 2021-07-07
2 Deerfield Mgmt, L.P. 20.66M 4.90% 20.66M PN Delaware 2021-07-07
3 Deerfield Partners, L.P. 20.66M 4.90% 20.66M PN Delaware 2021-07-07
4 James E. Flynn 20.66M 4.90% 20.66M IN Delaware 2021-07-07
5 JPMORGAN CHASE & CO13-2624428 19.84M 8.30% 17.38M 19.84M HC Delaware 2019-01-28
6 FMR LLC 17.68M 6.52% 17.68M HC United States of America 2020-02-07
7 The Vanguard Group - 23-1945930 13.17M 4.39% 523.1K 12.49M 679.2K IA 2021-02-10
8 JPMORGAN CHASE & CO.13-2624428 13.08M 4.30% 11.18M 13.04M HC Delaware 2020-12-09
9 Abigail P. Johnson 11.79M 5.44% 11.79M IN Delaware 2018-06-11
10 Wellington Management Company LLP 11.61M 5.91% 11.61M IA Delaware 2016-10-11
11 Wellington Group Holdings LLP 5.79M 2.94% 5.79M HC Delaware 2017-02-09
12 Wellington Investment Advisors Holdings LLP 5.79M 2.94% 5.79M HC Delaware 2017-02-09
13 Wellington Management Group LLP 5.79M 2.94% 5.79M HC Massachusetts 2017-02-09
14 David Rosen 1.72M 18.27% 1.72M 10.00 IN United States of America 2022-08-08
15 Rubric Capital Management LP 1.72M 18.27% 1.72M 10.00 IA, PN State of Delaware 2022-08-08
16 52-0556948 649.8K 0.10% 107.2K 649.8K IA Maryland 2022-02-14
17 Clearline Capital LLC 636.6K 5.52% 636.6K 636.6K HC Delaware 2024-11-12
18 Clearline Capital LP 636.6K 5.52% 636.6K 636.6K IA, PN Delaware 2024-11-12
19 Marc Majzner 636.6K 5.52% 636.6K 636.6K HC, IN Delaware 2024-11-12
20 Beryl Capital Management LLC 126.2K 11.00% 126.2K 126.2K OO Delaware 2022-06-03
21 Beryl Capital Management LP 126.2K 11.00% 126.2K 126.2K PN Delaware 2022-06-03
22 David A. Witkin 126.2K 11.00% 126.2K 126.2K HC Delaware 2022-06-03
23 (1) BlackRock, Inc. 122.1K 1.40% 122.0K 122.1K HC Delaware 2022-07-08
24 Beryl Capital Partners II LP 111.3K 11.00% 111.3K 111.3K PN Delaware 2022-06-03

Institutional Activity (13F)

Institutional ownership trend From To
13F snapshot — 2026 Q1
Investors holding
19
-25 vs prev Q
New positions
6
Closed positions
29
Increased
10
Reduced
2
Put/Call ratio
0.00
Calls held
12.3K
Puts held
Top institutional holders
# Investor Shares / Δ Mkt value / Δ Own% / Δ Weight% / Δ Avg px / Perf. Hold / Status
1 RUBRIC CAPITAL MANAGEMENT LP 1.19M +— (+0.0%) 1.94M +661.7K (+51.6%) 10.30% +0.000 pp 0.02% +0.009 pp USD7.77 -79.0% 15 qtrs
2 CLEARLINE CAPITAL LP 635.2K +— (+0.0%) 1.04M +352.5K (+51.6%) 5.49% +0.000 pp 0.05% +0.020 pp USD3.94 -58.6% 13 qtrs
3 VANGUARD GROUP INC 397.1K +20.2K (+5.4%) 647.2K +247.8K (+62.0%) 3.43% +0.175 pp 0.00% +0.000 pp USD8.15 -80.0% 15 qtrs
4 TEJARA CAPITAL LTD 350.9K +6.6K (+1.9%) 571.9K +201.9K (+54.6%) 3.03% +0.057 pp 0.13% -0.058 pp USD5.03 -67.6% 13 qtrs
5 ADAR1 CAPITAL MANAGEMENT, LLC 209.2K +— (+0.0%) 341.0K +116.1K (+51.6%) 1.81% +0.000 pp 0.03% +0.004 pp USD2.25 -27.6% 9 qtrs
6 MORGAN STANLEY 129.2K -1.4K (-1.0%) 210.6K +70.3K (+50.1%) 1.12% -0.012 pp 0.00% +0.000 pp USD9.89 -83.5% 15 qtrs
7 BLACKROCK, INC. 116.1K +— (+0.0%) 189.3K +64.5K (+51.6%) 1.00% +0.000 pp 0.00% +0.000 pp USD1.66 -1.8% 6 qtrs
8 GEODE CAPITAL MANAGEMENT, LLC 106.1K -3.0K (-2.7%) 173.0K +57.3K (+49.6%) 0.92% -0.026 pp 0.00% +0.000 pp USD4.32 -62.3% 15 qtrs
9 RENAISSANCE TECHNOLOGIES LLC 96.5K +61.0K (+171.8%) 157.3K +119.1K (+312.2%) 0.83% +0.527 pp 0.00% +0.000 pp USD1.40 +16.4% 5 qtrs
10 STATE STREET CORP 30.1K +— (+0.0%) 49.1K +17.2K (+53.8%) 0.26% +0.000 pp 0.00% +0.000 pp USD5.37 -69.6% 15 qtrs
11 SUSQUEHANNA INTERNATIONAL GROUP, LLP 24.1K +24.1K (+100.0%) 39.3K +39.3K (+100.0%) 0.21% +0.208 pp 0.00% +0.000 pp USD1.63 +0.0% 3 qtrs
12 CITADEL ADVISORS LLC 20.6K +20.6K (+100.0%) 33.6K +33.6K (+100.0%) 0.18% +0.178 pp 0.00% +0.000 pp USD1.63 +0.0% 14 qtrs
13 BRIDGEWAY CAPITAL MANAGEMENT, LLC 17.0K -17.0K (-50.0%) 27.7K -8.3K (-23.1%) 0.15% -0.147 pp 0.00% 0.000 pp USD5.96 -72.7% 14 qtrs
14 NORTHERN TRUST CORP 16.4K -9.0 (-0.1%) 26.8K +9.1K (+51.6%) 0.14% 0.000 pp 0.00% +0.000 pp USD5.52 -70.5% 15 qtrs
15 JANE STREET GROUP, LLC 12.2K +12.2K (+100.0%) 19.9K +19.9K (+100.0%) 0.11% +0.105 pp 0.00% +0.000 pp USD1.63 +0.0% 1 qtrs NEW
16 ADVISOR GROUP HOLDINGS, INC. 9.3K +8.4K (+936.5%) 15.2K +14.2K (+1,459.0%) 0.08% +0.073 pp 0.00% +0.000 pp USD1.57 +3.8% 15 qtrs
17 FMR LLC 8.3K +1.0 (+0.0%) 13.5K +4.7K (+53.8%) 0.07% +0.000 pp 0.00% +0.000 pp USD9.95 -83.6% 15 qtrs
18 TOWER RESEARCH CAPITAL LLC (TRC) 2.5K -262.0 (-9.6%) 4.0K +1.1K (+37.1%) 0.02% -0.002 pp 0.00% +0.000 pp USD1.34 +21.6% 11 qtrs
19 GROUP ONE TRADING, L.P. 1.6K +1.6K (+100.0%) 2.6K +2.6K (+100.0%) 0.01% +0.014 pp 0.00% +0.000 pp USD1.63 +0.0% 1 qtrs NEW
20 UBS GROUP AG 1.1K +752.0 (+207.7%) 1.8K +1.4K (+365.4%) 0.01% +0.007 pp 0.00% +0.000 pp USD1.49 +9.4% 15 qtrs
21 SMARTLEAF ASSET MANAGEMENT LLC 601.00 +601.0 (+100.0%) 986.00 +986.0 (+100.0%) 0.01% +0.005 pp 0.00% +0.000 pp USD1.63 +0.0% 1 qtrs NEW
22 NATIONAL BANK OF CANADA /FI/ 610.00 -60.0 (-9.0%) 976.00 +266.0 (+37.5%) 0.01% -0.001 pp 0.00% +0.000 pp USD5.51 -70.4% 15 qtrs
23 JPMORGAN CHASE & CO 293.00 +— (+0.0%) 477.00 +167.0 (+53.9%) 0.00% +0.000 pp 0.00% +0.000 pp USD7.91 -79.4% 15 qtrs
24 SBI SECURITIES CO., LTD. 255.00 +— (+0.0%) 416.00 +142.0 (+51.8%) 0.00% +0.000 pp 0.00% +0.000 pp USD0.86 +89.5% 5 qtrs
25 US BANCORP \DE\ 246.00 +— (+0.0%) 401.00 +137.0 (+51.9%) 0.00% +0.000 pp 0.00% +0.000 pp USD6.89 -76.3% 15 qtrs
26 BNP PARIBAS ARBITRAGE, SNC 226.00 +— (+0.0%) 368.00 +125.0 (+51.4%) 0.00% +0.000 pp 0.00% +0.000 pp USD0.86 +89.5% 5 qtrs
27 HUNTINGTON NATIONAL BANK 120.00 +— (+0.0%) 196.00 +67.0 (+51.9%) 0.00% +0.000 pp 0.00% +0.000 pp USD5.58 -70.8% 15 qtrs
28 BANK OF AMERICA CORP /DE/ 108.00 +2.0 (+1.9%) 176.00 +62.0 (+54.4%) 0.00% +0.000 pp 0.00% +0.000 pp USD2.90 -43.8% 15 qtrs
29 ACTIVEST WEALTH MANAGEMENT 40.00 +— (+0.0%) 65.00 +22.0 (+51.2%) 0.00% +0.000 pp 0.00% +0.000 pp USD1.70 -4.1% 7 qtrs
30 WELLS FARGO & COMPANY/MN 37.00 +— (+0.0%) 60.00 +20.0 (+50.0%) 0.00% +0.000 pp 0.00% +0.000 pp USD9.54 -82.9% 15 qtrs
31 STEWARD PARTNERS INVESTMENT ADVISORY, LLC 35.00 +— (+0.0%) 57.00 +19.0 (+50.0%) 0.00% +0.000 pp 0.00% +0.000 pp USD0.91 +79.1% 4 qtrs
32 FARTHER FINANCE ADVISORS, LLC 30.00 +— (+0.0%) 49.00 +17.0 (+53.1%) 0.00% +0.000 pp 0.00% +0.000 pp USD0.90 +81.1% 4 qtrs
33 IFP ADVISORS, INC 21.00 +— (+0.0%) 34.00 +11.0 (+47.8%) 0.00% +0.000 pp 0.00% +0.000 pp USD2.14 -23.8% 8 qtrs
34 PROVENANCE WEALTH ADVISORS, LLC 20.00 +— (+0.0%) 33.00 +11.0 (+50.0%) 0.00% +0.000 pp 0.00% +0.000 pp USD3.00 -45.7% 10 qtrs
35 CIBC PRIVATE WEALTH GROUP, LLC 20.00 +20.0 (+100.0%) 33.00 +33.0 (+100.0%) 0.00% +0.000 pp 0.00% +0.000 pp USD1.60 +1.9% 1 qtrs NEW
36 TRUVESTMENTS CAPITAL LLC 10.00 +— (+0.0%) 16.00 +5.0 (+45.5%) 0.00% +0.000 pp 0.00% +0.000 pp USD0.90 +81.1% 4 qtrs
37 HARBOUR INVESTMENTS, INC. 8.00 +— (+0.0%) 13.00 +4.0 (+44.4%) 0.00% +0.000 pp 0.00% +0.000 pp USD5.50 -70.4% 13 qtrs
38 ASSETMARK, INC 4.00 +— (+0.0%) 7.00 +3.0 (+75.0%) 0.00% +0.000 pp 0.00% +0.000 pp USD1.50 +8.7% 8 qtrs
39 SMALLWOOD WEALTH INVESTMENT MANAGEMENT, LLC 2.00 +— (+0.0%) 3.00 +1.0 (+50.0%) 0.00% +0.000 pp 0.00% +0.000 pp USD0.50 +226.0% 4 qtrs
40 EVERSOURCE WEALTH ADVISORS, LLC 1.00 +— (+0.0%) 2.00 +1.0 (+100.0%) 0.00% +0.000 pp 0.00% +0.000 pp USD2.00 -18.5% 8 qtrs
41 STRATEGIC ADVOCATES LLC 1.00 +— (+0.0%) 2.00 +1.0 (+100.0%) 0.00% +0.000 pp 0.00% +0.000 pp USD1.00 +63.0% 2 qtrs
42 CITIGROUP INC 1.00 +— (+0.0%) 2.00 +1.0 (+100.0%) 0.00% +0.000 pp 0.00% +0.000 pp USD1.00 +63.0% 3 qtrs
43 TWO SIGMA SECURITIES, LLC -12.0K (-100.0%) -12.9K (-100.0%) 0.00% -0.103 pp 0.00% -0.002 pp USD 4 qtrs SOLD
44 J. GOLDMAN & CO LP -13.6K (-100.0%) -14.6K (-100.0%) 0.00% -0.117 pp 0.00% 0.000 pp USD 14 qtrs SOLD
45 BARCLAYS PLC -44.0 (-100.0%) -47.0 (-100.0%) 0.00% 0.000 pp 0.00% +0.000 pp USD 2 qtrs SOLD
46 NEWEDGE ADVISORS, LLC -1.0 (-100.0%) -1.0 (-100.0%) 0.00% +0.000 pp 0.00% +0.000 pp USD 5 qtrs SOLD
47 WEALTH WATCH ADVISORS, INC -22.0 (-100.0%) -24.0 (-100.0%) 0.00% 0.000 pp 0.00% +0.000 pp USD 2 qtrs SOLD
48 ADVISORY SERVICES NETWORK, LLC -14.0 (-100.0%) -15.0 (-100.0%) 0.00% 0.000 pp 0.00% +0.000 pp USD 2 qtrs SOLD
Ownership breakdown by holder

ETF Ownership

Top ETFs holding this stock Held by 14 ETFs in our universe
# ETF Weight Est. AUM exposure TER
1 Dimensional - US Sustainability Core 1 ETF DFSU 0.00% 7.3K 0.15%
2 Vanguard Extended Market ETF VXF 0.00% 228.8K 0.05%
3 Dimensional - US Core Equity 1 ETF DCOR 0.00% 6.2K 0.14%
4 Vanguard U.S. Total Market Index ETF (CAD-hedged) VUS.TO 0.00% 224.71 0.17%
5 Vanguard U.S. Total Market Shares Index ETF VTS.AX 0.00% 1.1K 0.03%
6 Vanguard U.S. Total Market Index ETF VUN.TO 0.00% 3.0K 0.17%
7 Vanguard Total Stock Market ETF VTI 0.00% 520.0K 0.03%
8 Dimensional - US Core Equity 2 ETF DFAC 0.00% 9.7K 0.17%
9 Vanguard All-Equity ETF Portfolio VEQT.TO 0.00% 1.1K 0.22%
10 Vanguard Growth ETF Portfolio VGRO.TO 0.00% 620.33 0.22%

Insider Activity

Insider Activity — Latest Quarter
Ratio by transactions
0.00
Bearish
Buys
4
Sells
0
Shares acquired
93.0K
Shares disposed
Cash buys
Cash sales
Net activity
+92,992
Insider buys vs sells (history) From To
Recent insider transactions From To
Date Person Role Transaction A/D Security Shares Price Value Owned after D/I Filing
2025-12-23 Thompson Tommy G Director P-Purchase A Common Stock 8,400 1.67 14.0K 23,179 D
2025-11-03 Walker Marlan D Officer A-Award A Non-Qualified Stock Option (right to buy) 67,492 1.15 77.6K 67,492 D
2025-11-03 Thompson Tommy G Director A-Award A Restricted Stock Units 8,500 0.00 8,500 D
2025-11-03 Naughton Gail K Director A-Award A Restricted Stock Units 8,500 0.00 8,500 D
2025-11-03 Collins Cooper C. Director A-Award A Restricted Stock Units 8,500 0.00 8,500 D
2025-04-14 Walker Marlan D Officer P-Purchase A Common Stock 490 1.00 489.27 73,639 D
2025-04-14 Thompson Tommy G Director P-Purchase A Common Stock 325 1.00 325.59 14,779 D
2025-04-10 Walker Marlan D Officer P-Purchase A Common Stock 1,167 0.86 1.0K 73,149 D
2025-04-09 Walker Marlan D Officer P-Purchase A Common Stock 1,136 0.87 993.66 71,982 D
2025-02-18 Walker Marlan D Officer M-Exempt A Common Stock 1,733 0.00 70,846 D
2025-02-18 Thompson Tommy G Director M-Exempt D Restricted Stock Units 8,500 0.00 0 D
2025-02-18 Naughton Gail K Director M-Exempt D Restricted Stock Units 8,500 0.00 0 D
2025-02-18 Collins Cooper C. Director M-Exempt D Restricted Stock Units 8,500 0.00 0 D
2024-08-22 Collins Cooper C. Director P-Purchase A Common Stock 4,094 1.73 7.1K 52,016
2024-08-21 Collins Cooper C. Director P-Purchase A Common Stock 1,200 1.70 2.0K 47,922
2023-12-07 Walker Marlan D Officer S-Sale D Common Stock 4,550 2.24 10.2K 62,565
2023-12-06 Walker Marlan D Officer S-Sale D Common Stock 14,500 2.31 33.5K 67,115
2023-12-05 Walker Marlan D Officer M-Exempt A Common Stock 70,000 0.00 81,615
2023-11-15 Rubric Capital Management LP Director / 10% Owner A-Award A Common Stock, par value $0.001 per share ("Common Stock") 877,192 2.28 2.00M 2,946,908
2023-08-17 ZIEGLER JOSEPH Officer 0 0.00 0
2023-07-17 Thompson Tommy G Director A-Award A Restricted Stock Units 8,500 0.00 8,500
2023-07-17 Naughton Gail K Director A-Award A Restricted Stock Unit 8,500 0.00 8,500
2023-07-17 Collins Cooper C. Director A-Award A Restricted Stock Units 8,500 0.00 8,500
2023-06-28 Rubric Capital Management LP Director / 10% Owner A-Award A Common Stock, par value $0.001 per share ("Common Stock") 312,525 3.68 1.15M 2,069,716
2023-04-26 Walker Marlan D Officer M-Exempt A Common Stock 1,010 0.00 14,041
2023-04-12 Walker Marlan D Officer M-Exempt D Restricted Stock Units 1,734 0.00 3,466
2023-04-12 Donegan Michael C Officer M-Exempt A Common Stock 50,000 0.00 61,853
2023-02-21 Walker Marlan D Officer A-Award A Restricted Stock Units 70,000 0.00 70,000
2023-02-21 Donegan Michael C Officer A-Award A Restricted Stock Units 50,000 0.00 50,000
2023-01-27 Donegan Michael C Officer S-Sale D Common Stock 49 5.09 249.41 11,853
2023-01-26 Donegan Michael C Officer M-Exempt A Common Stock 2,400 0.00 12,410
2023-01-24 Donegan Michael C Officer S-Sale D Common Stock 7 5.31 37.17 7,610
2023-01-23 Donegan Michael C Officer M-Exempt A Common Stock 2,400 0.00 8,919
2022-12-31 Walker Marlan D Officer 0 0.00 0
2022-12-30 Rubric Capital Management LP Director / 10% Owner D-Return D Series A Preferred Stock, par value $0.001 per share 29,000 1,333.00 38.66M 0
2022-12-09 Rubric Capital Management LP Director P-Purchase A Common Stock, par value $0.001 per share ("Common Stock") 14,825 6.09 90.3K 1,757,191
2022-12-09 Bernick Brian Officer S-Sale D Common Stock 320 6.31 2.0K 3,872
2022-12-08 Rubric Capital Management LP Director P-Purchase A Common Stock 300 5.83 1.7K 1,742,366
2022-12-07 Rubric Capital Management LP Director P-Purchase A Common Stock, par value $0.001 per share ("Common Stock") 20,113 5.66 113.9K 1,742,066
2022-12-07 Naughton Gail K Director S-Sale D Common Stock 3,922 5.26 20.6K 0
2022-12-06 Walker Marlan D Officer M-Exempt A Common Stock 1,010 0.00 6,189
2022-12-06 Glickman Mark A Officer S-Sale D Common Stock 440 4.92 2.2K 1,294
2022-12-06 Donegan Michael C Officer M-Exempt A Common Stock 262 0.00 5,464
2022-12-06 Bernick Brian Officer M-Exempt D Restricted Stock Units 3,167 0.00 10,517
2022-10-28 Rubric Capital Management LP Director P-Purchase A Series A Preferred Stock, par value $0.001 per share 7,000 1,000.00 7.00M 29,000
2022-09-30 Rubric Capital Management LP 10% Owner P-Purchase A Series A Preferred Stock, par value $0.001 per share 7,000 1,000.00 7.00M 22,000
2022-09-30 Rosen David Efraim Director P-Purchase A Series A Preferred Stock, par value $0.001 per share 7,000 1,000.00 7.00M 22,000
2022-09-29 Thompson Tommy G Director A-Award A Restricted Stock Units 34,175 0.00 34,175
2022-09-29 Russell Angus C. Director A-Award A Restricted Stock Units 5,000 0.00 5,000
2022-09-29 Naughton Gail K Director A-Award A Restricted Stock Units 5,000 0.00 5,000
2022-09-29 MUSING JULES A. Director A-Award A Restricted Stock Units 5,000 0.00 5,000
2022-09-29 Ling Karen Director A-Award A Restricted Stock Units 5,000 0.00 5,000
2022-09-29 Collins Cooper C. Director A-Award A Restricted Stock Units 5,000 0.00 5,000
2022-09-29 BISARO PAUL Director A-Award A Restricted Stock Units 5,000 0.00 5,000
2022-09-06 Bernick Brian Officer D Restricted Stock Units 13,684 0.00 0
2022-08-23 Roberts Justin Hunter Director 0 0.00 0
2022-08-18 Thompson Tommy G Director M-Exempt D Restricted Stock Units 2,976 0.00 0
2022-08-18 Russell Angus C. Director M-Exempt A Common Stock 1,984 0.00 5,792
2022-08-18 Naughton Gail K Director M-Exempt D Restricted Stock Units 1,984 0.00 0
2022-08-18 MUSING JULES A. Director M-Exempt D Restricted Stock Units 1,984 0.00 0
2022-08-18 Ling Karen Director M-Exempt D Restricted Stock Units 1,984 0.00 0
2022-08-18 Collins Cooper C. Director M-Exempt D Restricted Stock Units 1,984 0.00 0
2022-08-18 BISARO PAUL Director M-Exempt D Restricted Stock Units 1,984 0.00 0
2022-07-29 Rubric Capital Management LP 10% Owner P-Purchase A Common Stock, par value $0.001 per share ("Common Stock") 565,000 4.72 2.67M 1,721,953
2022-07-29 Rosen David Efraim Director P-Purchase A Series A Preferred Stock, par value $0.001 per share 15,000 822.21 12.33M 15,000
2022-07-18 Rubric Capital Management LP 10% Owner P-Purchase A Common Stock 17,688 6.03 106.7K 1,156,953
2022-07-15 Rubric Capital Management LP 10% Owner P-Purchase A Common Stock, par value $0.001 per share ("Common Stock") 64,892 5.56 360.8K 1,139,265
2022-07-15 Rosen David Efraim Director P-Purchase A Common Stock 17,688 6.03 106.7K 1,156,953
2022-07-14 Rubric Capital Management LP 10% Owner I Common stock, par value $0.001 per share 0 0.00 1,074,373
2022-03-31 Walker Marlan D Officer A-Award A Performance Stock Units 260,000 0.00 260,000
2022-03-31 O'Dowd Hugh Officer A-Award A Performance Stock Units 2,125,000 0.00 2,125,000
2022-03-31 Glickman Mark A Officer A-Award A Performance Stock Units 260,000 0.00 260,000
2022-03-31 Donegan Michael C Officer A-Award A Performance Stock Units 120,000 0.00 120,000
2022-03-23 Walker Marlan D Officer A-Award A Restricted Stock Units 260,000 0.00 260,000
2022-03-23 O'Dowd Hugh Officer A-Award A Restricted Stock Units 2,125,000 0.00 2,125,000
2022-03-23 Glickman Mark A Officer A-Award A Restricted Stock Units 260,000 0.00 260,000
2022-03-23 Donegan Michael C Officer A-Award A Restricted Stock Units 120,000 0.00 120,000
2022-03-14 Walker Marlan D Officer M-Exempt A Common Stock 230,000 0.00 258,908
2021-11-30 Donegan Michael C Officer M-Exempt A Common Stock 115,000 0.00 129,158
2021-11-18 Collins Cooper C. Director P-Purchase A Common Stock 1,000,000 0.58 578.5K 2,236,864
2021-10-15 Glickman Mark A Officer A-Award A Restricted Stock Units 260,000 0.00 260,000
2021-09-29 Walker Marlan D Officer J-Other D Non-Qualified Stock Option (right to buy) 150,000 6.26 939.0K 0
2021-09-29 Donegan Michael C Officer J-Other D Non-Qualified Stock Option (right to buy) 100,000 5.16 516.0K 0
2021-08-31 O'Dowd Hugh Officer A-Award A Performance Stock Units 2,750,000 0.00 2,750,000
2021-08-18 Collins Cooper C. Director P-Purchase A Common Stock 900,000 0.72 648.0K 1,236,864
2021-08-17 Ling Karen Director P-Purchase A Common Stock 33,445 0.75 25.1K 130,309
2021-08-17 Collins Cooper C. Director P-Purchase A Common Stock 100,000 0.77 77.0K 336,864
2021-08-16 BISARO PAUL Director P-Purchase A Common Stock 50,000 0.79 39.5K 196,864
2021-08-13 Thompson Tommy G Director P-Purchase A Common Stock 11,000 0.87 9.6K 715,600
2021-08-12 DArecca James Officer S-Sale D Common Stock 93,337 0.87 81.2K 123,830
2021-08-10 Thompson Tommy G Director M-Exempt D Restricted Stock Units 145,296 0.00 0
2021-08-10 Russell Angus C. Director M-Exempt D Restricted Stock Units 96,864 0.00 0
2021-08-10 Naughton Gail K Director M-Exempt D Restricted Stock Units 96,864 0.00 0
2021-08-10 MUSING JULES A. Director M-Exempt D Restricted Stock Units 96,864 0.00 0
2021-08-10 Ling Karen Director M-Exempt A Common Stock 96,864 0.00 96,864
2021-08-10 DArecca James Officer M-Exempt A Common Stock 217,167 0.00 217,167
2021-08-10 Collins Cooper C. Director M-Exempt D Restricted Stock Units 96,864 0.00 0
2021-08-10 CARROLL J MARTIN Director M-Exempt A Common Stock 96,864 0.00 106,864
2021-08-10 BISARO PAUL Director M-Exempt D Restricted Stock Units 96,864 0.00 0
2021-08-03 O'Dowd Hugh Officer 0 0.00 0
2021-07-01 Walker Marlan D Officer A-Award A Performance Stock Units 346,667 0.00 346,667
2021-07-01 Thompson Tommy G Director A-Award A Restricted Stock Units 148,760 0.00 148,760
2021-07-01 Russell Angus C. Director A-Award A Restricted Stock Units 99,174 0.00 99,174
2021-07-01 Naughton Gail K Director A-Award A Restricted Stock Units 99,174 0.00 99,174
2021-07-01 MUSING JULES A. Director A-Award A Restricted Stock Units 99,174 0.00 99,174
2021-07-01 Ling Karen Director A-Award A Restricted Stock Units 99,174 0.00 99,174
2021-07-01 Finizio Robert G Director / Officer A-Award A Restricted Stock Units 746,667 0.00 746,667
2021-07-01 Donegan Michael C Officer A-Award A Performance Stock Units 160,000 0.00 160,000
2021-07-01 DArecca James Officer A-Award A Performance Stock Units 346,667 0.00 346,667
2021-07-01 Collins Cooper C. Director A-Award A Restricted Stock Units 99,174 0.00 99,174
2021-07-01 CARROLL J MARTIN Director A-Award A Restricted Stock Units 99,174 0.00 99,174
2021-07-01 BORKOWSKI EDWARD Officer A-Award A Restricted Stock Units 186,667 0.00 186,667
2021-07-01 BISARO PAUL Director A-Award A Restricted Stock Units 99,174 0.00 99,174
2021-05-14 Thompson Tommy G Director P-Purchase A Common Stock 5,000 1.06 5.3K 704,600
2021-05-11 Walker Marlan D Officer S-Sale D Common Stock 21,592 1.04 22.5K 28,908
2021-05-11 Milligan John C.K. IV Officer S-Sale D Common Stock 44,252 1.04 46.0K 1,752,703
2021-05-11 Finizio Robert G Director / Officer S-Sale D Common Stock 67,697 1.04 70.4K 17,991,637
2021-05-11 Donegan Michael C Officer S-Sale D Common Stock 4,842 1.04 5.0K 14,158
2021-05-11 BORKOWSKI EDWARD Officer S-Sale D Common Stock 44,252 1.04 46.0K 59,248
2021-05-10 Walker Marlan D Officer M-Exempt A Common Stock 50,500 0.00 50,500
2021-05-10 Milligan John C.K. IV Officer M-Exempt D Restricted Stock Units 103,500 0.00 207,000
2021-05-10 Finizio Robert G Director / Officer M-Exempt D Restricted Stock Units 158,334 0.00 316,666
2021-05-10 Donegan Michael C Officer M-Exempt D Restricted Stock Units 19,000 0.00 38,000
2021-05-10 BORKOWSKI EDWARD Officer M-Exempt A Common Stock 103,500 0.00 103,500
2021-03-30 Walker Marlan D Officer D Restricted Stock Units 151,500 0.00 0
2021-03-30 BORKOWSKI EDWARD Officer D Non-Qualified Stock Option (right to buy) 125,000 1.07 133.8K 0
2021-03-05 Finizio Robert G Director / Officer G-Gift D Common Stock 350,000 0.00 18,201,000
2021-03-04 Milligan John C.K. IV Officer X-InTheMoney D Warrant (right to buy) 179,000 0.24 43.7K 0
2021-03-04 Finizio Robert G Director / Officer X-InTheMoney D Warrants (right to buy) 179,000 0.24 43.7K 0
2020-11-24 Milligan John C.K. IV Officer A-Award A Restricted Stock Units 360,000 0.00 360,000
2020-11-24 Finizio Robert G Director / Officer A-Award A Restricted Stock Unit 1 0.00 1
2020-11-24 Donegan Michael C Officer A-Award A Restricted Stock Units 230,000 0.00 230,000
2020-08-01 Walker Marlan D Officer D Performance Stock Units 151,500 0.00 0
2020-08-01 BORKOWSKI EDWARD Officer D Performance Stock Units 310,500 0.00 0
2020-07-30 Walker Marlan D Officer D Non-Qualified Stock Option (right to buy) 200,000 2.18 436.0K 0
2020-06-18 Thompson Tommy G Director A-Award A Restricted Stock Units 145,296 0.00 145,296
2020-06-18 Russell Angus C. Director A-Award A Restricted Stock Units 96,864 0.00 96,864
2020-06-18 Naughton Gail K Director A-Award A Restricted Stock Units 96,864 0.00 96,864
2020-06-18 MUSING JULES A. Director A-Award A Restricted Stock Units 96,864 0.00 96,864
2020-06-18 Ling Karen Director A-Award A Restricted Stock Units 96,864 0.00 96,864
2020-06-18 DArecca James Officer A-Award A Restricted Stock Units 651,500 0.00 651,500
2020-06-18 Collins Cooper C. Director A-Award A Restricted Stock Units 96,864 0.00 96,864
2020-06-18 CARROLL J MARTIN Director A-Award A Restricted Stock Units 96,864 0.00 96,864
2020-06-18 BISARO PAUL Director A-Award A Restricted Stock Units 96,864 0.00 96,864
2020-06-09 Finizio Robert G Director / Officer P-Purchase A Common Stock 25,000 1.47 36.8K 18,401,964
2020-06-08 Collins Cooper C. Director P-Purchase A Common Stock 47,500 1.45 68.9K 140,000
2020-06-05 Milligan John C.K. IV Officer G-Gift D Common Stock 434,814 0.00 0
2020-06-05 Finizio Robert G Director / Officer P-Purchase A Common Stock 20,000 1.15 23.0K 18,355,964
2020-06-04 Thompson Tommy G Director P-Purchase A Common Stock 8,700 1.13 9.8K 699,600
2020-06-04 BISARO PAUL Director P-Purchase A Common Stock 50,000 1.14 57.0K 50,000
2020-06-01 DArecca James Officer 0 0.00 0
2020-04-16 Ling Karen Director 0 0.00 0
2020-03-30 Milligan John C.K. IV Officer A-Award A Performance Stock Units 310,500 0.00 310,500
2020-03-30 Krassan Mitchell Officer A-Award A Restricted Stock Units 151,500 0.00 151,500
2020-03-30 Finizio Robert G Director / Officer A-Award A Restricted Stock Units 475,000 0.00 475,000
2020-03-30 Donegan Michael C Officer A-Award A Restricted Stock Units 57,000 0.00 57,000
2020-03-30 Cartwright Daniel A Officer A-Award A Restricted Stock Units 151,500 0.00 151,500
2020-03-20 Naughton Gail K Director 0 0.00 0
2020-03-20 BISARO PAUL Director 0 0.00 0
2020-02-28 Finizio Robert G Director / Officer G-Gift D Common Stock 300,000 0.00 17,901,000
2020-02-03 Krassan Mitchell Officer M-Exempt A Common Stock 105,703 0.19 19.8K 105,703
2019-10-25 Milligan John C.K. IV Director / Officer P-Purchase A Common Stock 72,000 2.75 198.0K 1,544,419
2019-10-25 Finizio Robert G Director / Officer P-Purchase A Common Stock 72,000 2.75 198.0K 18,325,964
2019-10-25 Bernick Brian Director P-Purchase A Common Stock 36,000 2.75 99.0K 98,000
2019-08-28 Milligan John C.K. IV Officer A-Award A Non-Qualified Stock Option (right to buy) 400,000 2.73 1.09M 400,000
2019-08-28 Krassan Mitchell Officer A-Award A Non-Qualified Stock Option (right to buy) 300,000 2.73 819.0K 300,000
2019-08-28 Finizio Robert G Director / Officer A-Award A Non-Qualified Stock Option (right to buy) 1 2.73 2.73 1
2019-08-28 Donegan Michael C Officer A-Award A Non-Qualified Stock Option (right to buy) 120,000 2.73 327.6K 120,000
2019-08-28 Cartwright Daniel A Officer A-Award A Non-Qualified Stock Option (right to buy) 220,000 2.73 600.6K 220,000
2019-08-28 Bernick Brian Director A-Award A Non-Qualified Stock Option (right to buy) 300,000 2.73 819.0K 300,000
2019-08-23 Russell Angus C. Director P-Purchase A Common Stock 10,000 2.77 27.7K 93,500
2019-08-20 Finizio Robert G Director / Officer P-Purchase A Common Stock 35,000 2.74 95.9K 18,253,964
2019-08-16 Milligan John C.K. IV Director / Officer P-Purchase A Common Stock 10,000 2.93 29.3K 3,582,373
2019-08-15 Russell Angus C. Director P-Purchase A Common Stock 10,000 2.99 29.9K 83,500
2019-08-14 Russell Angus C. Director P-Purchase A Common Stock 25,000 2.76 69.0K 73,500
2019-08-12 Milligan John C.K. IV Director / Officer P-Purchase A Common Stock 15,000 3.16 47.4K 3,572,373
2019-08-12 Barlow Jane F Director P-Purchase A Common Stock 3,144 3.18 10.0K 3,144
2019-08-09 Thompson Tommy G Director P-Purchase A Common Stock 5,000 3.04 15.2K 690,900
2019-08-09 Finizio Robert G Director / Officer P-Purchase A Common Stock 52,405 2.96 155.1K 18,218,964
2019-08-09 Bernick Brian Director P-Purchase A Common Stock 10,000 2.87 28.7K 62,000
2019-06-20 Thompson Tommy G Director A-Award A Non-Qualified Stock Option (right to buy) 112,500 2.64 297.0K 112,500
2019-06-20 SEGAL NICHOLAS Director A-Award A Non-Qualified Stock Option (right to buy) 75,000 2.64 198.0K 75,000
2019-06-20 Russell Angus C. Director A-Award A Non-Qualified Stock Option (right to buy) 75,000 2.64 198.0K 75,000
2019-06-20 MUSING JULES A. Director A-Award A Non-Qualified Stock Option (right to buy) 75,000 2.64 198.0K 75,000
2019-06-20 LaPenta Robert V Jr Director A-Award A Non-Qualified Stock Option (right to buy) 75,000 2.64 198.0K 75,000
2019-06-20 Collins Cooper C. Director A-Award A Non-Qualified Stock Option (right to buy) 75,000 2.64 198.0K 75,000
2019-06-20 CARROLL J MARTIN Director A-Award A Non-Qualified Stock Option (right to buy) 75,000 2.64 198.0K 75,000
2019-06-20 Barlow Jane F Director A-Award A Non-Qualified Stock Option (right to buy) 75,000 2.64 198.0K 75,000
2019-05-13 Thompson Tommy G Director P-Purchase A Common Stock 2,400 3.34 8.0K 685,900
2019-05-13 Collins Cooper C. Director P-Purchase A Common Stock 30,000 3.33 99.9K 66,000
2019-03-15 Walker Marlan D Officer D Non-Qualified Stock Option (right to buy) 120,000 5.16 619.2K 0
2019-02-28 Finizio Robert G Director / Officer G-Gift D Common Stock 200,000 0.00 18,166,559
2019-02-27 MUSING JULES A. Director S-Sale D Common Stock 17,400 5.80 100.9K 5,000
2018-12-20 Finizio Robert G Director / Officer M-Exempt A Common Stock 92,910 0.10 9.5K 18,459,469
2018-12-19 Finizio Robert G Director / Officer S-Sale D Common Stock 92,000 3.70 340.2K 18,366,559
2018-12-18 Milligan John C.K. IV Director / Officer S-Sale D Common Stock 129,127 3.64 469.6K 1,472,419
2018-12-17 Milligan John C.K. IV Director / Officer M-Exempt A Common Stock 129,000 0.10 13.1K 1,601,419
2018-12-13 Bernick Brian Director M-Exempt D Non-Qualified Stock Option (right to buy) 91,910 0.10 9.4K 0
2018-12-12 Bernick Brian Director M-Exempt D Non-Qualified Stock Option (right to buy) 91,910 0.00 0
2018-12-07 Finizio Robert G Director / Officer M-Exempt A Common Stock 92,000 0.10 9.4K 18,458,559

Executive team

Top executives
EBIT / Employee
-4.21M
Shares Outstanding
11.57M

Executive compensation

Executive compensation (annual)
# Year Executive Salary Bonus Stock award Option award Incentive Other Total % Stock-
based
Filing
1 2024 Marlan D. Walker Chief Executive Officer 500.0K 250.0K 9.2K 759.2K 0.00%
2 2024 Joseph Ziegler Principal Financial and Accounting Officer 120.0K 120.0K 0.00%
3 2023 Michael Donegan Former Interim Chief Financial Officer 532.1K 160.5K 296.0K 333.9K 1.29M 23.01%
4 2023 Marlan D. Walker Chief Executive Officer 476.5K 176.5K 358.4K 8.4K 1.02M 35.14%
5 2023 Joseph Ziegler Principal Financial and Accounting Officer 52.9K 30.0K 82.9K 36.19%
6 2022 Hugh O’Dowd Former Chief Executive Officer 521.4K 2.39M 725.0K 26.0K 3.66M 65.28%
7 2022 Brian Bernick, M.D. Former Interim Co-Chief Executive Officer 500.0K 250.0K 292.7K 812.5K 18.9K 1.62M 18.02%
8 2022 Marlan D. Walker Chief Executive Officer 424.5K 207.5K 292.7K 622.5K 26.2K 1.57M 18.60%
9 2022 Mark Glickman Former Interim Co-Chief Executive Officer 408.5K 175.0K 292.7K 608.8K 118.9K 1.43M 20.48%
10 2022 Michael Donegan Former Interim Chief Financial Officer 307.3K 90.0K 135.1K 363.0K 18.9K 914.2K 14.77%
11 2022 James C. D’Arecca Former Chief Financial Officer 121.7K 86.2K 207.9K 0.00%
12 2021 Hugh O’Dowd Former Chief Executive Officer 273.0K 250.0K 4.37M 289.5K 4.93M 88.60%
13 2021 James C. D’Arecca Former Chief Financial Officer 420.0K 1.05M 126.0K 127.0K 1.72M 60.91%
14 2021 Marlan D. Walker Chief Executive Officer 415.0K 1.09M 66.4K 24.8K 1.60M 68.31%
15 2020 Edward Borkowski Executive Vice President, Operations 430.0K 3.60M 365.5K 81.7K 4.48M 80.41%
16 2020 Robert G. Finizio Chief Executive Officer 600.0K 1.52M 600.0K 21.8K 2.75M 55.52%
17 2020 John C.K. Milligan, IV President and Secretary 450.0K 1.48M 315.0K 31.3K 2.28M 65.00%
18 2019 John C.K. Milligan, IV President and Secretary 450.0K 646.0K 315.0K 29.7K 1.44M 44.84%
19 2019 Robert G. Finizio Chief Executive Officer 600.0K 2.00 600.0K 22.2K 1.22M 0.00%
20 2019 Mitchell L. Krassan Chief Strategy & Performance Officer 360.0K 484.5K 180.0K 20.5K 1.04M 46.36%
21 2019 Daniel A. Cartwright Chief Financial Officer and Treasurer 375.0K 355.3K 262.5K 21.8K 1.01M 35.02%
22 2019 Michael Donegan Vice President - Finance 290.0K 193.8K 72.5K 15.8K 572.1K 33.87%
23 2018 Robert G. Finizio Chief Executive Officer 600.0K 150.0K 1.36M 600.0K 18.4K 2.72M 49.78%
24 2018 John C.K. Milligan, IV President and Secretary 450.0K 78.8K 832.2K 315.0K 25.5K 1.70M 48.91%
25 2018 Daniel A. Cartwright Chief Financial Officer and Treasurer 375.0K 65.6K 524.0K 262.5K 18.4K 1.25M 42.07%
26 2018 Mitchell L. Krassan Chief Strategy & Performance Officer 360.0K 45.0K 524.0K 180.0K 20.4K 1.13M 46.40%
27 2018 Michael Donegan Vice President - Finance 290.0K 18.1K 308.2K 72.5K 14.6K 703.5K 43.82%
28 2017 Robert G. Finizio Chief Executive Officer 600.0K 40.0K 1.76M 570.0K 17.3K 2.98M 58.87%
29 2017 John C.K. Milligan, IV President and Secretary 450.0K 40.0K 1.03M 299.3K 24.4K 1.84M 55.78%
30 2017 Daniel A. Cartwright Chief Financial Officer and Treasurer 375.0K 40.0K 671.1K 249.4K 17.3K 1.35M 49.61%
31 2017 Mitchell L. Krassan Executive Vice President and Chief Strategy Officer 360.0K 671.1K 171.0K 19.3K 1.22M 54.94%
32 2017 Mitchell L. Krassan Chief Strategy & Performance Officer 360.0K 671.1K 171.0K 19.3K 1.22M 54.94%
33 2017 Michael Donegan Vice President - Finance 290.0K 157.9K 68.9K 14.7K 531.5K 29.71%
34 2016 Robert G. Finizio Chief Executive Officer 600.0K 50.0K 600.0K 13.3K 1.26M 0.00%
35 2016 John C.K. Milligan, IV President and Secretary 450.0K 315.0K 19.1K 784.1K 0.00%
36 2016 Daniel A. Cartwright Chief Financial Officer and Treasurer 375.0K 262.5K 14.1K 651.6K 0.00%
37 2016 Mitchell L. Krassan Chief Strategy & Performance Officer 300.0K 150.0K 15.6K 465.6K 0.00%
38 2016 Mitchell L. Krassan Executive Vice President and Chief Strategy Officer 300.0K 150.0K 15.6K 465.6K 0.00%
39 2016 Michael Donegan Vice President - Finance 290.0K 72.5K 12.2K 374.7K 0.00%
40 2015 Robert G. Finizio Chief Executive Officer 550.0K 4.57M 962.5K 15.2K 6.09M 74.93%
41 2015 John C.K. Milligan, IV President and Secretary 350.0K 2.40M 367.5K 20.4K 3.14M 76.50%
42 2015 Daniel A. Cartwright Chief Financial Officer, and Treasurer 345.0K 1.56M 362.3K 14.8K 2.28M 68.38%
43 2015 Daniel A. Cartwright Chief Financial Officer and Treasurer 345.0K 1.56M 362.3K 14.8K 2.28M 68.38%
44 2015 Mitchell L. Krassan Executive Vice President and Chief Strategy Officer 232.4K 720.8K 76.5K 11.3K 1.04M 69.24%
45 2015 Michael Donegan Vice President - Finance 180.0K 480.6K 36.0K 10.2K 706.8K 67.99%
46 2015 Michael Donegan Vice President of Finance 180.0K 480.6K 36.0K 10.2K 706.8K 67.99%
47 2014 Robert G. Finizio Chief Executive Officer 550.0K 65.0K 615.0K 0.00%
48 2014 John C.K. Milligan, IV President and Secretary 350.0K 139.1K 65.0K 554.1K 25.10%
49 2014 Mitchell L. Krassan Executive Vice President and Chief Strategy Officer 213.2K 197.9K 15.0K 12.4K 438.5K 45.14%
50 2014 Daniel A. Cartwright Chief Financial Officer and Treasurer 345.0K 12.4K 357.4K 0.00%
51 2014 Daniel A. Cartwright Chief Financial Officer, and Treasurer 345.0K 12.4K 357.4K 0.00%
52 2014 Mitchell L. Krassan Executive Vice President and Chief Strategy Officer Michael Donegan Vice President of Finance 150.0K 161.2K 20.0K 10.4K 341.6K 47.20%
53 2014 Michael Donegan Vice President - Finance 150.0K 161.2K 20.0K 10.4K 341.6K 47.20%
54 2014 Michael Donegan Vice President of Finance 150.0K 161.2K 20.0K 10.4K 341.6K 47.20%
55 2013 Robert G. Finizio Chief Executive Officer 355.1K 93.2K 124.3K 44.2K 616.8K 0.00%
56 2013 John C.K. Milligan, IV President and Secretary 288.1K 75.6K 57.5K 86.4K 43.3K 551.0K 10.43%
57 2013 Daniel A. Cartwright Chief Financial Officer, and Treasurer 257.1K 67.5K 76.8K 8.1K 409.5K 0.00%
58 2013 Daniel A. Cartwright Chief Financial Officer, Vice President of Finance, and Treasurer 257.1K 67.5K 76.8K 8.1K 409.5K 0.00%
59 2013 Mitchell L. Krassan Executive Vice President and Chief Strategy Officer 200.0K 16.7K 8.4K 225.1K 0.00%
60 2012 Robert G. Finizio Chief Executive Officer 194.3K 1.44M 19.1K 1.66M 87.11%
61 2012 Robert G. Finizio . Chief Executive Officer 194.3K 1.39M 19.1K 1.60M 86.68%
62 2012 John C.K. Milligan, IV President and Secretary 181.4K 1.26M 18.2K 1.46M 86.36%
63 2012 John C.K. Milligan, IV President and Secretary 181.4K 1.34M 18.2K 1.46M 91.85%
64 2012 Daniel A. Cartwright Chief Financial Officer, Vice President of Finance, and Treasurer 184.7K 857.5K 7.8K 1.07M 80.29%
65 2012 Daniel A. Cartwright Chief Financial Officer, Vice President of Finance, and Treasurer 184.7K 857.5K 7.8K 1.07M 80.29%
66 2012 Mitchell L. Krassan Executive Vice President and Chief Strategy Officer 120.5K 1.3K 121.8K 0.00%
67 2012 Mitchell L. Krassan Executive Vice President and Chief Strategy Officer 120.5K 1.3K 121.8K 0.00%
68 2011 Daniel A. Cartwright Chief Financial Officer, Vice President of Finance, and Treasurer 79.6K 179.3K 730.00 259.6K 69.05%
69 2011 Daniel A. Cartwright Chief Financial Officer, Vice President of Finance, and Treasurer 79.6K 179.3K 730.00 259.6K 69.05%
70 2011 John C.K. Milligan, IV President and Secretary 156.0K 25.3K 181.3K 0.00%
71 2011 John C.K. Milligan, IV President and Secretary 156.0K 25.3K 181.3K 0.00%
72 2011 Robert G. Finizio Chief Executive Officer 156.0K 16.0K 172.0K 0.00%
73 2011 Robert G. Finizio . Chief Executive Officer 156.0K 16.0K 172.0K 0.00%
74 2011 Mitchell L. Krassan Executive Vice President and Chief Strategy Officer 110.0K 110.0K 0.00%
75 2011 Mitchell L. Krassan Executive Vice President and Chief Strategy Officer 110.0K 110.0K 0.00%
76 2010 John C.K. Milligan, IV President and Secretary 144.8K 9.6K 154.3K 0.00%
77 2010 Robert G. Finizio . Chief Executive Officer 140.3K 2.3K 142.5K 0.00%
78 2010 Mitchell L. Krassan Executive Vice President and Chief Strategy Officer 15.1K 62.3K 77.4K 80.50%
79 2010 Daniel A. Cartwright Chief Financial Officer, Vice President of Finance, and Treasurer
CEO compensation breakdown

Proxy statements

Proxy statements (DEF 14A)
Filing date Form type Filing
2025-11-03 DEFA14A
2025-11-03 DEF 14A
2025-10-24 PRE 14A
2024-10-25 DEFA14A
2024-10-25 DEF 14A
2023-05-17 DEFA14A
2023-05-17 DEF 14A
2023-05-01 PRE 14A

Recent SEC filings

Recent SEC filings
Filing date Form type Filing
2026-05-12 8-K
2026-05-12 10-Q
2026-04-06 SC 13G
2026-04-01 NT 10-K
2026-04-01 10-K/A
2026-03-30 8-K
2026-03-30 10-K
2026-01-21 8-K
2025-12-29 4
2025-12-16 8-K

Executive team

NameTitleCompensationGender
Marlan D. Walker Chief Executive Officer 511.1K male
Joseph A. Ziegler Principal Financial & Accounting Officer 120.0K male
Douglas Steelman Vice President of Market Access male
ESG Rating
B-
DRUG MANUFACTURERS - SPECIALTY & GENERIC
Rank: 112 out of 119
2014
E (Environmental)
57.2 / 66.0
Company / Sector avg.
S (Social)
65.4 / 70.0
Company / Sector avg.
G (Governance)
63.4 / 66.6
Company / Sector avg.
ESG Total
62.0 / 67.5
Company / Sector avg.
ESG Score History DRUG MANUFACTURERS - SPECIALTY & GENERIC
Benchmark vs Sector
Senate Trading Activity

No Senate trading activity found for this company.

House Trading Activity

No House trading activity found for this company.

Market share among peers
Peer comparison — filtered group (TTM)
Your opinion

Share your view on this stock and instantly see how the community has voted over the last 6 months.

These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

Dividend history

Earnings history

Earnings reports

Stock splits